http://www.rncos.com/Report/IM153.htm
bolding mine
Not news to some, but well worth reading if you want to see which vaccines are expected to be on the schedule in the near future.
Quote:
| Segment-wise, pediatric vaccines presently dominate the global vaccine market but adult vaccine segments will define the future direction of growth. The cancer vaccine market, led by cervical cancer vaccines, is presently one of the most lucrative areas for vaccine manufacturers. Overall, cancer vaccines are expected to account for nearly 27% of the total vaccine revenues by 2012. Owing to lower margins and the mature nature of these markets, the basic and enhanced pediatric markets are expected to show stagnant growth in future. On the other hand, launch of a number of new vaccines will make the addiction, cancer and proprietary pediatrics/adolescent vaccine market highly dynamic. On a whole, the global vaccine market is expected to register revenues in excess of US$ 30 Billion by 2012. |
Not news to some, but well worth reading if you want to see which vaccines are expected to be on the schedule in the near future.










